Mara Aspinall
President & Chief Executive Officer, On-Q-ity
Anna Barker, Ph.D.
Deputy Director, Strategic Scientific Initiatives, NIH
Jane Barlow
Vice President, Medical Strategy & Clinical Quality, Medco
Mark Boguski, M.D., Ph.D.
Department of Pathology, Beth Israel Deaconess Medical Center
Michael Bristow, M.D., Ph.D.
Chief Executive Officer, ARCA biopharma
William Chin, M.D.
Executive Dean for Research, Harvard Medical School
Neil de Crescenzo
Senior Vice President and General Manager, Oracle Health Sciences Global Business Unit
Mikael Dolsten, M.D., Ph.D.
President, Pfizer Worldwide Research & Development
Jennifer Gordon
Partner, Baker Botts LLP
William Hagstrom
Chief Executive Officer, Crescendo Bioscience
Richard Hamermesh, D.B.A.
MBA Class of 1961 Professor of Management Practice, Harvard Business School
Christopher Hansen, Esq.
Senior National Staff Counsel, American Civil Liberties Union
Anthony Hess, Ph.D.
Senior Vice President & General Manager, Health Solutions, SAIC
David Hickey
Executive Vice President, Central Laboratory & Global Research & Development, Siemens Healthcare Diagnostics
Peter Hirth, Ph.D.
Chief Executive Officer, Plexxikon
Katherine Holland
General Manager, Global Life Sciences Industry, IBM
Carolyn Johnson
Science Writer, The Boston Globe
Raju Kucherlapati, Ph.D.
Professor of Genetics, Professor of Medicine, Harvard Medical School
Lawrence Lesko, Ph.D.
Director of Clinical Pharmacology, CDER, FDA
Harlan Levine, M.D.
Principal, Towers Watson
Sharon Levine
Associate Executive Director, Permanente Medical Group
Clay Marsh, M.D.
Professor, Senior Associate Vice President for Health Sciences Research, Ohio State University
Hugh Martin,
Chief Executive Officer, Pacific Biosciences
Christopher-Paul Milne, D.V.M., M.P.H., J.D.
Associate Director, Tufts Center for the Study of Drug Development
Arnold Milstein, M.D., M.P.H.
Chief Physician and US Thought Leader, Mercer Health & Benefits
Elizabeth Nabel, M.D.
President, Brigham and Women’s Hospital, Faulkner Hospital
Ryan Phelan
President, DNA Direct
Emad Rizk
President, McKesson Health Solutions
Sue Siegel
Partner, MDV-Mohr Davidow Ventures
Mark Stevenson
President & Chief Operating Officer, Life Technologies
Guillerme Suarez-Kurtz, M.D., Ph.D.
Head of Pharmacology, Brazilian National Cancer Institute, Coordinator, Brazilian National Pharmacogenomics Network (REFARGEN)
Charles Swanton, Ph.D.
Head, Translational Cancer Therapeutics, London branch, Cancer Research UK
Scott Weiss, M.D., M.S.
Scientific Director, Partners Center for Personalized Genetic Medicine, Professor of Medicine, Harvard Medical School
Back to top